Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study
Sammy Huygens(Ghent University Hospital), Bart Rijnders(Rega Institute for Medical Research), Birgit C. P. Koch(Erasmus MC), Francis Swaneveld(Sanquin), Ilona Kleine Budde, Corine H. GeurtsvanKessel(Pulmonary Associates), Tim Preijers(Erasmus MC)
Cited by 5
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
|Science Immunology|2021|591
Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells
|The Journal of Experimental Medicine|2008|465
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
|Science Immunology|2022|438